Healthcare provider profile · identity verified

Lovelesh K Manocha, M.D.

Internal Medicine · SAN ANTONIO, TX · NPI 1407960552

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Montelukast Sodium	Montelukast Sodium	613	209
Atorvastatin Calcium	Atorvastatin Calcium	584	170
Metformin Hcl	Metformin Hcl	430	127
Amlodipine Besylate	Amlodipine Besylate	424	128
Levothyroxine Sodium	Levothyroxine Sodium	423	119
Losartan Potassium	Losartan Potassium	402	115
Rosuvastatin Calcium	Rosuvastatin Calcium	358	112
Ozempic	Semaglutide	341	61
Gabapentin	Gabapentin	280	81
Omeprazole	Omeprazole	258	75
Mounjaro	Tirzepatide	236	52
Lisinopril	Lisinopril	217	59
Metoprolol Succinate	Metoprolol Succinate	187	50
Pantoprazole Sodium	Pantoprazole Sodium	177	58
Jardiance	Empagliflozin	170	44
Tamsulosin Hcl	Tamsulosin Hcl	158	54
Hydrochlorothiazide	Hydrochlorothiazide	157	45
Trazodone Hcl	Trazodone Hcl	153	41
Methylprednisolone	Methylprednisolone	152	107
Albuterol Sulfate Hfa	Albuterol Sulfate	151	57
Simvastatin	Simvastatin	147	40
Clopidogrel	Clopidogrel Bisulfate	134	38
Azithromycin	Azithromycin	132	99
Glipizide Er	Glipizide	130	41
Glipizide	Glipizide	126	37
Januvia	Sitagliptin Phosphate	114	27
Potassium Chloride	Potassium Chloride	112	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	112	29
Meloxicam	Meloxicam	109	41
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	105	81
Trulicity	Dulaglutide	105	24
Ibuprofen	Ibuprofen	103	38
Carvedilol	Carvedilol	100	33
Eliquis	Apixaban	93	21
Fluticasone Propionate	Fluticasone Propionate	93	34
Furosemide	Furosemide	93	34
Famotidine	Famotidine	92	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	25
Vitamin D2	Ergocalciferol (Vitamin D2)	90	35
Alprazolam	Alprazolam	88	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	49
Metoprolol Tartrate	Metoprolol Tartrate	86	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	28
Nifedipine Er	Nifedipine	85	26
Donepezil Hcl	Donepezil Hcl	84	32
Hydroxyzine Hcl	Hydroxyzine Hcl	84	29
Ezetimibe	Ezetimibe	82	25
Farxiga	Dapagliflozin Propanediol	82	24
Pravastatin Sodium	Pravastatin Sodium	81	21
Allopurinol	Allopurinol	80	23
Dicyclomine Hcl	Dicyclomine Hcl	78	35
Citalopram Hbr	Citalopram Hydrobromide	68	19
Enalapril Maleate	Enalapril Maleate	66	14
Meclizine Hcl	Meclizine Hcl	63	27
Escitalopram Oxalate	Escitalopram Oxalate	61	22
Pioglitazone Hcl	Pioglitazone Hcl	61	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	58	15
Sertraline Hcl	Sertraline Hcl	58	19
Olmesartan Medoxomil	Olmesartan Medoxomil	56	17
Alendronate Sodium	Alendronate Sodium	55	17
Hydrocortisone	Hydrocortisone	53	15
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	46	14
Bupropion Xl	Bupropion Hcl	44	12
Clonazepam	Clonazepam	44	suppressed
Warfarin Sodium	Warfarin Sodium	43	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	41	31
Synthroid	Levothyroxine Sodium	41	suppressed
Ramipril	Ramipril	40	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	39	12
Finasteride	Finasteride	37	11
Ondansetron Odt	Ondansetron	37	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	13
Paxlovid	Nirmatrelvir/Ritonavir	36	36
Doxycycline Hyclate	Doxycycline Hyclate	35	31
Levetiracetam	Levetiracetam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	11
Tramadol Hcl	Tramadol Hcl	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Myrbetriq	Mirabegron	34	11
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Gemfibrozil	Gemfibrozil	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	11
Levemir Flexpen	Insulin Detemir	28	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Lactulose	Lactulose	27	11
Linzess	Linaclotide	27	11
Cholestyramine	Cholestyramine (With Sugar)	26	suppressed
Topiramate	Topiramate	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Ssd	Silver Sulfadiazine	21	15
Clotrimazole	Clotrimazole	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Repatha Sureclick	Evolocumab	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	19	13
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Levofloxacin	Levofloxacin	18	13
Novolog Flexpen	Insulin Aspart	18	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	17	15
Valacyclovir	Valacyclovir Hcl	17	13
Xarelto	Rivaroxaban	17	suppressed
Colchicine	Colchicine	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Constulose	Lactulose	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Prednisone	Prednisone	14	suppressed
Baclofen	Baclofen	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Permethrin	Permethrin	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error